Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Video Interview from the BSH 2015: Dr Graham Collins: Autologous vs Allogenic transplantation in Hodgkin lymphoma – where do they fit in?

Written by | 2 Jun 2015

Dr Graham Collins from the Oxford Cancer and Haematology Centre, Oxford, UK.

Video Interview and editorial from the BSH 2015: Professor Graham Jackson discusses the journey from despair to hope in multiple myeloma. Click on the image for interview and editorial.

Written by | 1 Jun 2015

Graham Jackson, Professor of Clinical haematology, Newcastle upon Tyne and former president of the British Society for Haematology (BSH). Article by Christine Clark: In the 1970s the prospect… read more.

BTS Report 2014: Hypercoagulability in potential pancreas transplant recipients – the value of thromboelastography

Written by | 21 Apr 2014

Maria Dalby reporting on the Oral Presentation by Mari Kilner, Freeman Hospital, Newcastle upon Tyne- Thromboelastography is a method of testing the efficiency of coagulation which measures not… read more.

Protein modifies thyroid hormone levels according to body temperature

Written by | 13 Feb 2014

The thyroid hormone thyroxine, which controls our day-to-day activity and was previously believed to remain at a constant level in the blood, actually fluctuates as a result of… read more.

ASH 2012 Report – Reduced intensity regimen prior to marrow transplant better for older leukaemia patients

Written by | 21 Dec 2012

A new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC –… read more.

ASH 2012 Report – Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders

Written by | 21 Dec 2012

Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.

ASH 2012 Report – New stem cell research, transplant strategies show promise to improve outcomes, reduce complications

Written by | 21 Dec 2012

Studies of stem cell biology and transplant approaches presented at the 54th Annual Meeting of the American Society of Haematology (ASH) illustrate how the use of advanced modelling… read more.

ASH 2012 Report – New research helps predict susceptibility to Burkitt lymphoma

Written by | 21 Dec 2012

New research, presented at the 54th Annual Meeting of the American Society of Haematology (ASH), has identified important associations between Plasmodium falciparum (Pf) malaria and endemic Burkitt Lymphoma (eBL) that… read more.

ASH 2012 Report – New drug cuts risk of transplant side effect in half

Written by | 21 Dec 2012

by Sung Choi, M.D., University of Michigan Comprehensive Cancer Center (pictured) First study in humans shows promise for preventing graft-versus-host disease following bone marrow transplant.

ASH 2012 Report – Investigational agent targets gene signaling pathways to improve response for patients with CLL

Written by | 21 Dec 2012

The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic… read more.

ASH 2012 Report – Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial

Written by | 21 Dec 2012

An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3… read more.

ASH 2012 Report – Blood levels of immune protein predict risk in Hodgkin disease

Written by | 21 Dec 2012

Blood levels of an immunity-related protein, galectin-1, in patients with newly diagnosed Hodgkin lymphoma reflected the extent of their cancer and correlated with other predictors of outcome,

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.